EGFR and familial pancreatic carcinoma: Moreover, several studies have shown that EGFR inhibition has a pivotal role as an anti-tumor agent [197] and, for this reason, several drugs targeted against EGFR are currently employed for the treatment of head and neck, colorectal, lung and pancreatic cancer [198].